Activation of COL11A1 by PRRX1 promotes tumor progression and radioresistance in ovarian cancer
Authors:
- 25 May 2021
- journal article
- research article
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 97 (7) , 958-967
Abstract
Although radiotherapy is a common treatment option for all kinds of cancer patients, including ovarian cancer, a major obstacle limiting its application in the development of resistance. Therefore,...Keywords
Funding Information
- Jiangsu Provincial Key Department of Maternal and Child Health (12)
This publication has 31 references indexed in Scilit:
- The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesisGenes & Development, 2013
- Ionizing radiation, ion transports, and radioresistance of cancer cellsFrontiers in Physiology, 2013
- Metastatic Colonization Requires the Repression of the Epithelial-Mesenchymal Transition Inducer Prrx1Cancer Cell, 2012
- Radiation-induced Akt activation modulates radioresistance in human glioblastoma cellsRadiation Oncology, 2009
- New therapies for ovarian cancer: Cytotoxics and molecularly targeted agentsCritical Reviews in Oncology/Hematology, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Serine/Threonine Kinase AKT Is Frequently Activated in Human Bile Duct Cancer and Is Associated with Increased RadioresistanceCancer Research, 2004
- FAK induces expression of Prx1 to promote tenascin-C–dependent fibroblast migrationJournal of Cell Biology, 2003
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesisCell, 1995